282 related articles for article (PubMed ID: 23113773)
1. Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
Vitkauskiene A; Dambrauskiene A; Cerniauskiene K; Rimdeika R; Sakalauskas R
Scand J Infect Dis; 2013 Mar; 45(3):213-8. PubMed ID: 23113773
[TBL] [Abstract][Full Text] [Related]
2. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
Eser OK; Ergin A; Hasçelik G
Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
[TBL] [Abstract][Full Text] [Related]
4. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
Lu PL; Huang LY; Lian ST; Chang K; Lin CL; Hwang IJ; Chiang WG; Chen YH; Lin SF; Siu LK
Int J Antimicrob Agents; 2008 May; 31(5):463-6. PubMed ID: 18359613
[TBL] [Abstract][Full Text] [Related]
5. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
[TBL] [Abstract][Full Text] [Related]
6. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
7. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
[TBL] [Abstract][Full Text] [Related]
8. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
[TBL] [Abstract][Full Text] [Related]
9. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
13. High mortality associated with Acinetobacter species infection in liver transplant patients.
Kim YJ; Yoon JH; Kim SI; Hong KW; Kim JI; Choi JY; Yoon SK; You YK; Lee MD; Moon IS; Kim DG; Kang MW
Transplant Proc; 2011; 43(6):2397-9. PubMed ID: 21839276
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
15. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.
Maltezou HC; Kontopidou F; Katerelos P; Daikos G; Roilides E; Theodoridou M
Pediatr Infect Dis J; 2013 Apr; 32(4):e151-4. PubMed ID: 23249908
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Wu D; Cai J; Liu J
South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
[TBL] [Abstract][Full Text] [Related]
20. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
